Emerging bacterial pathogens: Escherichia coli, Enterobacter aerogenes and Proteus mirabilis clinical isolates harbouring the same transferable plasmid coding for metallo-β-lactamase VIM-1 in Greece
Open Access
- 25 January 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 59 (3), 578-579
- https://doi.org/10.1093/jac/dkl508
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Emergence of Proteus mirabilis carrying the blaVIM-1 metallo-β-lactamase geneClinical Microbiology & Infection, 2006
- VIM-1 Metallo-β-lactamase inAcinetobacter baumanniiEmerging Infectious Diseases, 2006
- Characterization of a new integron containing blaVIM-1 and aac(6′)-IIc in an Enterobacter cloacae clinical isolate from GreeceJournal of Antimicrobial Chemotherapy, 2005
- Metallo-β-Lactamases: the Quiet before the Storm?Clinical Microbiology Reviews, 2005
- First identification of an Escherichia coli clinical isolate producing both metalloβ-lactamase VIM-2 and extended-spectrum β-lactamase IBC-1Clinical Microbiology & Infection, 2004
- VIM-1 Metallo-β-Lactamase-Producing Klebsiella pneumoniae Strains in Greek HospitalsJournal of Clinical Microbiology, 2003
- Escherichia coli with a Self-Transferable, Multiresistant Plasmid Coding for Metallo-β-Lactamase VIM-1Antimicrobial Agents and Chemotherapy, 2003
- Transferable plasmid mediating resistance to multiple antimicrobial agents in Klebsiella pneumoniae isolates in GreeceClinical Microbiology & Infection, 2002
- Modified Hodge and EDTA-disk synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobactet speciesClinical Microbiology & Infection, 2001